Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis
Tóm tắt
Sarcopenia is characterized by a decline in muscle strength, muscle mass, and physical performance. Persistent inflammation may lead to muscle wasting. This research aims to determine the prevalence and associated factors of sarcopenia in axial spondyloarthritis (ax-SpA). A cross-sectional study of 104 ax-SpA patients who met the 2009 ASAS criteria was conducted at Phramongkutklao Hospital between January 2020 and February 2021. Sarcopenia-related factors and disease characteristics were recorded. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia 2019. Appendicular skeletal muscle mass was measured by dual-energy X-ray absorptiometry. Strength, ambulation, rising from a chair, stair climbing and history of falling (SARC-F) was evaluated. Muscle strength was measured by hand grip strength and chair stand time. Physical performance was assessed by 6-m walk and time up and go tests. Logistic regression was performed to identify factors associated with sarcopenia. Most patients were male (74%), with a mean (standard deviation, SD) age and disease duration of 42.6 (12.2) and 8.3 (8.5) years, respectively. The mean BMI (SD) was 23.8 (4.4). The prevalence of sarcopenia was 22.1%. There were no differences in disease activity (BASDAI and ASDAS) between ax-SpA patients with and without sarcopenia. Age, low BMI, and BASFI score were independently associated with sarcopenia, with adjusted odds ratios and 95% confidence intervals of 1.08 (1.01–1.16), 0.39 (0.25–0.63), and 1.41 (1.07–1.86), respectively. Sarcopenia is common in ax-SpA patients and is independently associated with older age, low BMI, and high BASFI score but not disease activity.
Tài liệu tham khảo
Ibanez Vodnizza S, Visman IM, van Denderen C, Lems WF, Jaime F, Nurmohamed MT et al (2017) Muscle wasting in male TNF-alpha blocker naive ankylosing spondylitis patients: a comparison of gender differences in body composition. Rheumatology (Oxford) 56(9):1566–1572
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423
Koon-Yee Lee G, Chun-Ming AuP, Hoi-Yee Li G, Chan M, Li HL, Man-Yung Cheung B et al (2021) Sarcopenia and mortality in different clinical conditions: a meta-analysis. Osteoporos Sarcopenia 7(Suppl 1):S19–S27
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K et al (2020) Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 21(3):300–7 e2
Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783
Kittiyanpanya C, Chaiamnuay S, Asavatanabodee P, Narongroeknawin P (2014) Reliability and validity of the Thai version of bath ankylosing spondylitis indices. J Med Assoc Thailand Chotmaihet thangphaet 97(4):381–5
Barbosa-Silva TG, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC, Grupo de EstudosemComposicao Corporal e N (2016) Enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 17(12):1136–1141
Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14(8):531–532
Auyeung TW, Arai H, Chen LK, Woo J (2020) Letter to the editor: normative data of handgrip strength in 26344 older adults - a pooled dataset from eight cohorts in Asia. J Nutr Health Aging 24(1):125–126
Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA crosscalibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom 22(4):453–471
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Mineral Res 31(5):940–948
Clynes MA, Gregson CL, Bruyere O, Cooper C, Dennison EM (2021) Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology (Oxford) 60(2):529–537
Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–8
Barone M, Viggiani MT, Anelli MG, Fanizzi R, Lorusso O, Lopalco G, Cantarini L, Di Leo A, Lapadula G, Iannnone F (2018) Sarcopenia in patients with rheumatic diseases: prevalence and associated risk factors. J Clin Med 7(12):504
El Maghraoui A, Ebo’o FB, Sadni S, Majjad A, Hamza T, Mounach A (2016) Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis? BMC Musculoskelet Disord 17:268
Song R, Choi JY, Lee YA, Hong SJ, Yang HI (2017) Prevalence of and factors associated with sarcopenia in patients of ankylosing spondylitis [abstract]. Arthritis Rheumatol 69
Sri-On J, Fusakul Y, Kredarunsooksree T, Paksopis T, Ruangsiri R (2022) The prevalence and risk factors of sarcopenia among Thai community-dwelling older adults as defined by the Asian Working Group for Sarcopenia (AWGS-2019) criteria: a cross-sectional study. BMC Geriatr 22(1):786
Liu C, Cheng KY, Tong X, Cheung WH, Chow SK, Law SW et al (2023) The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity. Front Endocrinol (Lausanne) 14:1077255
Yoo MC, Won CW, Soh Y (2022) Association of high body mass index, waist circumference, and body fat percentage with sarcopenia in older women. BMC Geriatr 22(1):937
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285
Aguiar R, Sequeira J, Meirinhos T, Ambrosio C, Barcelos A (2014) SARCOSPA - sarcopenia in spondyloarthritis patients. Acta Reumatol Port 39(4):322–326
Ben Tekaya A, Mehmli T, Ben Sassi M, Teyeb Z, Bouden S, Rouached L et al (2023) Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 42(4):979–997
Lee RC, Wang Z, Heo M, Ross R, Janssen I, Heymsfield SB (2000) Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr 72(3):796–803